It was also found that OSCC patients who suffered from disease stageI-II were more likely to have an up-regulated TPM1 expression level, and OSCC patients with lymph node metastasis had a higher probability of exhibiting reduced TPM1 expression. This evidence concerns the gene TPM1 and metastatic malignant neoplasm in the lymph nodes.